Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAINBO-RED: Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial Cancer
NCT06712472Phase 3Recruiting
- Sponsor
- Gustave Roussy
- Start
- Jun 2024
- Primary completion
- Jun 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olaparib in endometrial cancer (EC), sponsored by Gustave Roussy. Started Jun 2024; status: recruiting.
02
Drugs
olaparib
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT06712472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06712472.